{"nctId":"NCT01932060","briefTitle":"Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.","startDateStruct":{"date":"2013-08"},"conditions":["Postpartum Hemorrhage"],"count":51,"armGroups":[{"label":"Oxytocin Infusion 1","type":"EXPERIMENTAL","interventionNames":["Drug: Oxytocin Infusion"]},{"label":"Oxytocin Infusion 2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Oxytocin Infusion"]}],"interventions":[{"name":"Oxytocin Infusion","otherNames":["Oxytocin; Pitocin"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy pregnant patients with uncomplicated pregnancies:\n* ASA (American Association of Anesthesiologists) class 1 or 2 patients.\n* Singleton pregnancies.\n\nExclusion Criteria:\n\n* ASA class 3 or 4 patients.\n* Known drug allergy to intravenous oxytocin.\n* Significant medical or obstetric disease.\n* Known uterine abnormality.\n* Known placental abnormality.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"40 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Estimated Blood Loss","description":"Blood loss will be measured volumetrically (based on measured volume of blood within the suction chamber) and gravimetrically (based on blood weight on blood soaked laps).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"512","spread":null},{"groupId":"OG001","value":"634","spread":null}]}]}]},{"type":"SECONDARY","title":"Hemoglobin Indices After Cesarean Delivery","description":"Study investigators will assess maternal hemoglobin levels at 24hr after cesarean delivery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.","spread":null},{"groupId":"OG001","value":"11.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":[]}}}